Earnings
KTRA
1.330
+5.56%
0.070
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-06-30
2.39M
--
--
--
--
--
9400.00
--
--
--
355.58K
93.70K
2.85M
--
--
--
--
--
2110.00
--
84.94K
87.06K
2.94M
--
--
0.00
--
--
--
2.01M
--
--
--
--
--
663.87K
2.67M
0.00
--
--
--
--
0.00
2.67M
11.46K
56.62M
-61.20M
--
--
--
263.21K
263.21K
2.94M
FY 2019-06-30
3.72M
--
--
--
--
--
26.19K
--
--
--
280.25K
--
4.03M
--
--
--
--
--
12.06K
--
--
12.07K
4.04M
--
--
0.00
--
--
--
1.74M
--
--
--
--
--
325.21K
2.07M
0.00
--
--
--
0.00
0.00
2.07M
3840.00
50.95M
-53.99M
--
--
--
1.97M
1.97M
4.04M
FY 2018-06-30
5.97M
--
--
--
--
--
39.52K
--
--
--
1.03M
--
7.05M
--
--
--
--
--
28.41K
--
--
28.42K
7.07M
--
--
0.00
--
--
--
1.48M
--
--
--
--
--
160.43K
1.64M
0.00
--
--
--
1120.00
1110.00
1.64M
22.97K
43.18M
-44.21M
--
--
--
5.44M
5.44M
7.07M
FY 2017-06-30
6.59M
--
--
76.60K
--
--
76.60K
--
--
--
1.21M
--
7.87M
--
--
--
--
--
40.29K
--
--
40.29K
7.91M
--
--
0.00
--
--
--
1.18M
--
--
--
--
--
122.05K
1.30M
0.00
--
--
--
28.14K
28.14K
1.33M
14.51K
36.67M
-36.55M
--
--
--
6.58M
6.58M
7.91M
FY 2016-06-30
6.16M
--
--
18.39K
--
--
18.39K
--
--
--
144.13K
0.00
6.32M
--
--
--
--
--
36.02K
--
--
36.02K
6.36M
--
--
0.00
--
--
--
584.00K
--
--
--
--
--
43.44K
627.45K
0.00
--
--
--
869.58K
869.57K
1.50M
11.19K
28.83M
-30.58M
--
--
--
4.86M
4.86M
6.36M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out KTRA latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Kintara Therapeutics recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.